FilingSEC EDGAR8-K
CytoSorbents Effects 1-for-20 Reverse Stock Split
· SEC accepted
Filing content
The company effected a 1-for-20 reverse stock split effective September 8, 2026, with trading continuing on a split-adjusted basis.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…